Derivation of the critical effect size/benchmark response for the dose-response analysis of the uptake of radioactive iodine in the human thyroid. (22nd August 2016)

• Record Type: Journal Article
• Authors: Weterings, Peter J.J.M.; Loftus, Christine; Lewandowski, Thomas A.
• Is Part Of: Toxicology letters. Volume 257(2016)
• Page Start: 38
• Page End: 43
• Publication Date: 2016-08-22
• Subjects: Thyroid -- Radioiodine -- RAIU -- Intra-individual variation -- Benchmark dose analysis -- Benchmark response -- Critical effect size -- Perchlorate -- TDI -- Risk assessment; Toxicology -- Periodicals; 363.179
• DOI: 10.1016/j.toxlet.2016.06.004
• Languages: English
• ISSNs: 0378-4274

Abstract

Highlights: Intra-individual variation in the 24-h uptake of iodine by the thyroid is examined. For euthyroid adult subjects, a between-days difference of 20% is concluded. This inherent variation decreases the precision of relative RAIU data. A critical effect size (CES/BMR) of 20% is proposed for benchmark dose analysis. Abstract: Potential adverse effects of chemical substances on thyroid function are usually examined by measuring serum levels of thyroid-related hormones. Instead, recent risk assessments for thyroid-active chemicals have focussed on iodine uptake inhibition, an upstream event that by itself is not necessarily adverse. Establishing the extent of uptake inhibition that can be considered de minimis, the chosen benchmark response (BMR), is therefore critical. The BMR values selected by two international advisory bodies were 5% and 50%, a difference that had correspondingly large impacts on the estimated risks and health-based guidance values that were established. Potential treatment-related inhibition of thyroidal iodine uptake is usually determined by comparing thyroidal uptake of radioactive iodine (RAIU) during treatment with a single pre-treatment RAIU value. In the present study it is demonstrated that the physiological intra-individual variation in iodine uptake is much larger than 5%. Consequently, in-treatment RAIU values, expressed as a percentage of the pre-treatment value, have an inherent variation, that needs to be considered when conducting dose-response analyses. Based on statistical and biological considerations, a BMR of 20% is proposed for benchmark dose analysis of human thyroidal iodine uptake data, to take the inherent variation in relative RAIU data into account. Implications for the tolerated daily intakes for perchlorate and chlorate, recently established by the European Food Safety Authority (EFSA), are discussed.